Keros Therapeutics, Inc. (KROS)
11.02
+0.03
(+0.27%)
USD |
NASDAQ |
Mar 13, 16:00
11.00
-0.02
(-0.14%)
After-Hours: 20:00
Keros Therapeutics Total Assets (Quarterly) : 342.87M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 949.87M |
| MannKind Corp. | 792.18M |
| Sarepta Therapeutics, Inc. | 3.350B |
| PTC Therapeutics, Inc. | 2.911B |
| Insmed, Inc. | 2.265B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.74M |
| Shareholders Equity (Quarterly) | 303.13M |
| Debt to Equity Ratio | 0.0557 |
| Current Ratio | 15.45 |
| Net Debt Paydown Yield | 0.12% |